Back to Trades
STARR CHRISTOPHER M
DirectorCIK 0001235470
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 1
- Active
- 2025–2026
Across 3 filings between 2025–2026, STARR CHRISTOPHER M, Director, has disclosed $1.6M in transactions — all concentrated in Monopar Therapeutics (MNPR). Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.3M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Oct 5 | MNPR Monopar Therapeutics | STARR CHRISTOPHER M | Director | Sell | $659.4K |
| Dec 8 | MNPR Monopar Therapeutics | STARR CHRISTOPHER M | Director | Award | $222.0K |
| Jul 16 | MNPR Monopar Therapeutics | STARR CHRISTOPHER M | Director | Sell | $672.0K |
3 filings